Found: 46
Select item for more details and to access through your institution.
Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development and validation of a predictive model for failure of ureteral access sheath placement in patients with ureteral calculi.
- Published in:
- BMC Urology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12894-024-01606-5
- By:
- Publication type:
- Article
NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01392-4
- By:
- Publication type:
- Article
Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
- Published in:
- Clinical & Experimental Medicine, 2018, v. 18, n. 2, p. 165, doi. 10.1007/s10238-018-0488-3
- By:
- Publication type:
- Article
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
- Published in:
- NPJ Precision Oncology, 2020, v. 4, n. 1, p. 1, doi. 10.1038/s41698-020-00137-0
- By:
- Publication type:
- Article
KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
- Published in:
- Shock & Vibration, 2019, p. 1, doi. 10.1155/2019/4863182
- By:
- Publication type:
- Article
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
- Published in:
- Nucleic Acids Research, 2019, v. 47, n. 8, p. 4211, doi. 10.1093/nar/gkz108
- By:
- Publication type:
- Article
Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/4782730
- By:
- Publication type:
- Article
KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/4863182
- By:
- Publication type:
- Article
Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.778850
- By:
- Publication type:
- Article
Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.886983
- By:
- Publication type:
- Article
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Post-transcriptional modification of m<sup>6</sup>A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 4, p. 1, doi. 10.1038/s41419-023-05773-5
- By:
- Publication type:
- Article
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 3, p. 1, doi. 10.1038/s41419-023-05742-y
- By:
- Publication type:
- Article
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 11, p. 1, doi. 10.1038/s41419-022-05366-8
- By:
- Publication type:
- Article
DNA‐repair status should be assessed in treatment‐emergent neuroendocrine prostate cancer before platinum‐based therapy.
- Published in:
- Prostate, 2022, v. 82, n. 4, p. 464, doi. 10.1002/pros.24292
- By:
- Publication type:
- Article
Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells.
- Published in:
- Prostate, 2013, v. 73, n. 12, p. 1306, doi. 10.1002/pros.22676
- By:
- Publication type:
- Article
The Expression of Neurotensin in Animal Model of Androgen Independent Prostate Cancer.
- Published in:
- Tianjin Medical Journal, 2014, v. 42, n. 9, p. 878, doi. 10.3969/j.issn.0253-9896.2014.09.008
- By:
- Publication type:
- Article
Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 786, doi. 10.3390/vaccines9070786
- By:
- Publication type:
- Article
Increased KIF4A expression is a potential prognostic factor in prostate cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 5, p. 7941, doi. 10.3892/ol.2018.8322
- By:
- Publication type:
- Article
Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4364, doi. 10.3892/ol.2017.6010
- By:
- Publication type:
- Article
[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8602
- By:
- Publication type:
- Article
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 921, doi. 10.3892/or.2021.7920
- By:
- Publication type:
- Article
Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
- Published in:
- Oncology Reports, 2018, v. 40, n. 2, p. 959, doi. 10.3892/or.2018.6476
- By:
- Publication type:
- Article
Unveiling novel insights in prostate cancer through single-cell RNA sequencing.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1224913
- By:
- Publication type:
- Article
Increased CK5/CK8-Positive Intermediate Cells with Stromal Smooth Muscle Cell Atrophy in the Mice Lacking Prostate Epithelial Androgen Receptor.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0020202
- By:
- Publication type:
- Article
P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02777-z
- By:
- Publication type:
- Article
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2023, v. 36, n. 1, p. 23, doi. 10.36721/PJPS.2023.36.1.REG.023-029.1
- By:
- Publication type:
- Article
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
- Published in:
- Medical Science Monitor, 2018, v. 24, p. 8190, doi. 10.12659/MSM.912643
- By:
- Publication type:
- Article
Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-022-03860-3
- By:
- Publication type:
- Article
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
- Published in:
- Molecular Carcinogenesis, 2016, v. 55, n. 12, p. 2278, doi. 10.1002/mc.22468
- By:
- Publication type:
- Article
Epidemiological and clinical characteristics of stone composition: a single-center retrospective study.
- Published in:
- Urolithiasis, 2022, v. 50, n. 1, p. 37, doi. 10.1007/s00240-021-01274-2
- By:
- Publication type:
- Article
Development and validation of CT imaging–based preoperative nomogram in the prediction of unfavorable high-grade small renal masses.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 8731, doi. 10.2147/CMAR.S186914
- By:
- Publication type:
- Article
Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 3599, doi. 10.2147/CMAR.S159105
- By:
- Publication type:
- Article
Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals.
- Published in:
- Cancer Management & Research, 2017, v. 9, p. 679, doi. 10.2147/CMAR.S141670
- By:
- Publication type:
- Article
Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 11, p. 2817, doi. 10.1007/s00345-022-04170-5
- By:
- Publication type:
- Article
CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 5, p. 1, doi. 10.1002/ctm2.1230
- By:
- Publication type:
- Article
Genetic Probe Enhanced MRI: Enhancing Prostate‐Cancer‐Specific MRI by Genetic Amplified Nanoparticle Tumor Homing (Adv. Mater. 30/2019).
- Published in:
- Advanced Materials, 2019, v. 31, n. 30, p. N.PAG, doi. 10.1002/adma.201970218
- By:
- Publication type:
- Article
Enhancing Prostate‐Cancer‐Specific MRI by Genetic Amplified Nanoparticle Tumor Homing.
- Published in:
- Advanced Materials, 2019, v. 31, n. 30, p. N.PAG, doi. 10.1002/adma.201970218
- By:
- Publication type:
- Article
One-Stage Flexible Ureteroscopy during Single-Tract Percutaneous Nephrolithotomy in the Treatment of Parallel Calyceal Stones.
- Published in:
- Urologia Internationalis, 2022, v. 106, n. 12, p. 1233, doi. 10.1159/000525591
- By:
- Publication type:
- Article
YAP is required for prostate development, regeneration, and prostate stem cell function.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01637-1
- By:
- Publication type:
- Article
YAP is required for prostate development, regeneration, and prostate stem cell function.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01637-1
- By:
- Publication type:
- Article
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-1542-z
- By:
- Publication type:
- Article